Mohammad Sarhadi
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 1
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Saman Sargazi (9 shared papers)Fatemeh Davodabadi (3 shared papers)Shekoufeh Mirinejad (6 shared papers)Ramin Saravani (7 shared papers)Milad Heidari Nia (5 shared papers)Mohsen Rokni (3 shared papers)Marco Cordani (1 shared paper)Mohsen Basiri (1 shared paper)
In The Last Decade
Mohammad Sarhadi
13 papers receiving 255 citations
Peers
Comparison fields: 5 of 69
- Infectious Diseases 58
- Biomaterials 36
- Immunology 47
- Oncology 35
- Molecular Biology 88
Countries citing papers authored by Mohammad Sarhadi
This map shows the geographic impact of Mohammad Sarhadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sarhadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sarhadi more than expected).
Fields of papers citing papers by Mohammad Sarhadi
This network shows the impact of papers produced by Mohammad Sarhadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sarhadi. The network helps show where Mohammad Sarhadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Sarhadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 90 | |
| 2 | 2022 | 48 | |
| 3 | 2022 | 35 | |
| 4 | 2021 | 30 | |
| 5 | 2022 | 25 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 4 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2022 | 2 | |
| 12 | Response of Crop Yield and Yield Components of Melon to Different Tillage Methods in the Arid Lands of Iran | 2011 | 2 |
| 13 | 2024 | 1 | |
| 14 | 2025 | 0 |
About Mohammad Sarhadi
Mohammad Sarhadi is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Oncology and Cancer Research, having authored 14 papers that have together received 257 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Cancer-related molecular mechanisms research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Immunotherapy and Immune Responses (2 papers), Nanoplatforms for cancer theranostics (2 papers), Plant Physiology and Cultivation Studies (1 paper), Hepatitis B Virus Studies (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Infectious Diseases (58 citations), Biomaterials (36 citations), Immunology (47 citations), Oncology (35 citations) and Molecular Biology (88 citations). Mohammad Sarhadi has collaborated with scholars based in Iran, Australia and Spain. Frequent co-authors include Saman Sargazi, Fatemeh Davodabadi, Shekoufeh Mirinejad, Ramin Saravani, Milad Heidari Nia, Mohsen Rokni, Marco Cordani, Mohsen Basiri, Saeid Ghavami and Abbas Rahdar. Their work appears in journals such as Biochemical Genetics, European Journal of Pharmacology, Journal of Controlled Release, International Journal of Environmental Research and Public Health and Applied Biochemistry and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.